Finance

Beta
Lists
KTTAW:NASDAQ
Pasithea Therapeutics
$0.0068
+3.03%
(+0.00020) 1D
Jun 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KTTAW...
Open
$0.01
High
$0.01
Low
$0.01
Mkt. cap
19.39M
Avg. vol.
11.00K
Volume
1.53K
52-wk high
$0.12
52-wk low
$0.00
Beta
0.81
No. of employees
5
Open
$0.01
High
$0.01
Low
$0.01
Mkt. cap
19.39M
Avg. vol.
11.00K
Volume
1.53K
52-wk high
$0.12
52-wk low
$0.00
Beta
0.81
No. of employees
5
News stories
From sources across the web
About Pasithea Therapeutics
CEO-
Employees5
Founded2020
HeadquartersMiami Beach, Florida, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.15M
1.36M
2.74M
2.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.66M
1.75M
3.35M
1.93M
Operating expense
3.81M
3.11M
6.09M
4.88M
Total operating expenses
3.81M
3.11M
6.09M
4.88M
Operating income
-3.81M
-3.11M
-6.09M
-4.88M
Other non operating income
11.03K
55.49K
-64.17K
1.57M
EBT including unusual items
-3.72M
-3.04M
-10.11M
-2.87M
EBT excluding unusual items
-3.72M
-3.04M
-5.95M
-2.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.72M
-3.04M
-10.11M
-2.87M
Net profit margin
-
-
-
-
Earnings per share
-
-
-0.89
-0.12
Interest and investment income
54.42K
43.40K
182.13K
450.34K
Interest expense
-
-
-
-
Net interest expenses
54.42K
43.40K
182.13K
450.34K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.65M
-2.93M
-5.93M
-4.72M
Gain or loss from assets sale
-
-
103.32K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more